A₃ Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity

The overexpression of the A₃ adenosine receptor (AR) in a number of cancer cell types makes it an attractive target for tumor diagnosis and therapy. Hence, in the search for new A₃AR ligands, a series of novel 2,<i>N</i>⁶-disubstituted adenosines (Ados) was synthesiz...

Description complète

Détails bibliographiques

Auteurs principaux:	Andrea Spinaci, Michela Buccioni, Diego Dal Ben, Federica Maggi, Gabriella Marucci, Beatrice Francucci, Giorgio Santoni, Catia Lambertucci, Rosaria Volpini
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2022-01-01
Collection:	Pharmaceuticals
Sujets:	A<sub>3</sub> adenosine receptors A<sub>3</sub> adenosine receptor antagonists adenosine derivatives anticancer activity sulforhodamine B assay
Accès en ligne:	https://www.mdpi.com/1424-8247/15/2/164
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!